Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
K36 Therapeutics, Inc.
Eli Lilly and Company
Pfizer
Alterome Therapeutics, Inc.
Massachusetts General Hospital
Eli Lilly and Company
Orca Biosystems, Inc.
Boston Scientific Corporation
VA Office of Research and Development
M.D. Anderson Cancer Center
Stemline Therapeutics, Inc.
Pfizer
DL Analytics